US 10745702
Compositions and methods for inhibiting expression of the LECT2 gene
granted A61KA61K31/712A61K31/7125
Quick answer
US patent 10745702 (Compositions and methods for inhibiting expression of the LECT2 gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/712, A61K31/7125, A61K47/26, A61P